Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
09:01am, Wednesday, May 14, 2025
Company Overview: IO Biotech, Inc. (NASDAQ: IOBT) is a clinical-stage biopharmaceutical company focused on developing novel immune-modulatory therapeutic cancer vaccines utilizing its T-win® platform.
Recent Income Statement Highlights for Q1 2025:
Net Loss: $22.4 million, compared to $19.5 mill...
09:00am, Wednesday, May 14, 2025
Company Overview: Sow Good Inc. (PINK: SOWG) is a U.S.-based manufacturer focused on freeze-dried candy and snacks. The company has transitioned from its previous focus on oil and gas to specialized food production, launching products in 2023.
Key Financial Highlights (Q1 2025):
Revenues: $2.48 ...
08:06am, Wednesday, May 14, 2025
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) has presented its unaudited financial results for the three months ended March 31, 2025, highlighting several key developments and challenges facing the company.
**Key Financial Highlights:**
Revenue: No revenue reported for Q1 2025 or Q1 2024.
Opera...
08:06am, Wednesday, May 14, 2025
HG Holdings, Inc. (NASDAQ: STLY) has recently released its Q1 2025 financial results, highlighting various significant developments in its operations and financial position.
Positive Aspects:
Total Revenues: Increased to $2.722 million in Q1 2025, a modest rise from $2.699 million in Q1 2024.
Gr...
08:05am, Wednesday, May 14, 2025
Company Overview
ARS Pharmaceuticals, Inc. (NASDAQ: SBTX) is a biopharmaceutical company focusing on the commercialization and development of neffy, a needle-free intranasal delivery system for epinephrine, which is used for the emergency treatment of Type I allergic reactions including anaphylax...
08:05am, Wednesday, May 14, 2025
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) has recently released its quarterly report for the period ending March 31, 2025. Below is a summary of key financial aspects and company developments for the period.
Positive Aspects:
Net Income: For Q1 2025, Unicycive reported a net income of $570,000...
08:04am, Wednesday, May 14, 2025
Foghorn Therapeutics Inc. (NASDAQ: FHTX)
Foghorn Therapeutics, a clinical-stage biopharmaceutical company, focuses on developing a new class of medicines targeting the chromatin regulatory system. They are at the forefront of creating novel oncology drugs, leveraging their proprietary Gene Traffi...
08:04am, Wednesday, May 14, 2025
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) has recently provided financial updates for the quarter ended March 31, 2025, revealing both positive and negative aspects of its performance.
Positive Aspects:
Total revenues increased slightly to $1.3 million from $1.1 million year-over-year, indica...
08:04am, Wednesday, May 14, 2025
Charlotte's Web Holdings, Inc. (OTCBB: CWBHF) has recently reported its financial results for the quarter ending March 31, 2025. Below are key observations derived from the latest income statement and financial performance metrics.
Positive Aspects:
Total revenue for Q1 2025 was $12,262,000, a 1...
08:03am, Wednesday, May 14, 2025
Benitec Biopharma Inc. (NASDAQ: BNTC) has released its quarterly financial report for the period ending March 31, 2025, revealing insights into its ongoing operations and financial health.
Income Statement Highlights:
Revenue: No revenue recognized during the three and nine months ended March 31...
08:03am, Wednesday, May 14, 2025
Climb Bio, Inc. (NASDAQ: CLYM) has recently provided a detailed overview of their financial performance for Q1 2025, which highlights both significant challenges and opportunities within the company.
Key Aspects from Income Statement:
Net Loss: The company reported a net loss of $20.8 million fo...
08:03am, Wednesday, May 14, 2025
Company Overview
Centessa Pharmaceuticals plc (NASDAQ: CNTA) is a clinical-stage pharmaceutical company based in the UK, focused on developing innovative therapies for unmet medical needs. The company's strategy leverages a differentiated asset-centric approach to build a diverse pipeline aimed a...
08:02am, Wednesday, May 14, 2025
Company Overview:
Scholar Rock Holding Corporation (NASDAQ: SRRK) is a late-stage biopharmaceutical company focused on developing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases. The company is recognized for its proprietary platform technol...
08:02am, Wednesday, May 14, 2025
Company Overview
Verve Therapeutics, Inc. (NASDAQ: VERV) is a clinical-stage company focused on developing a new class of genetic medicines for cardiovascular disease (CVD). The company's innovative approach seeks to transform chronic therapies into single-course gene editing medicines, particula...
08:01am, Wednesday, May 14, 2025
Company Overview
Advanced Flower Capital Inc. (NASDAQ: AFCG) primarily engages in providing financing to cannabis industry operators in states where cannabis is legal. The company, externally managed by AFC Management, LLC, originates loans secured by various assets, including real estate and cas...
